Chiral enantioresolution of cathinone derivatives present in “legal highs”, and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV)
Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this...
Saved in:
| Published in | Forensic toxicology Vol. 34; no. 2; pp. 372 - 385 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Tokyo
Springer
01.07.2016
Springer Japan |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in "legal highs" acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized "legal highs" in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylose tris-3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of S-(-)-MDPV and R-(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model. |
|---|---|
| AbstractList | Abstract
Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in “legal highs” acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized “legal highs” in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylose
tris
-3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of
S
-(−)-MDPV and
R
-(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model. Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in “legal highs” acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized “legal highs” in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylose tris -3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of S -(−)-MDPV and R -(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model. Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in “legal highs” acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized “legal highs” in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylose tris -3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of S -(−)-MDPV and R -(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model. Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in "legal highs" acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized "legal highs" in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylose tris-3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of S-(-)-MDPV and R-(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model. Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in "legal highs" acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized "legal highs" in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylose -3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of -(-)-MDPV and -(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model. |
| Author | Fernandes, Carla Tiritan, Maria Elizabeth Guedes de Pinho, Paula Carvalho, Marcia Silva, Bárbara Pinto, Madalena M.M. Valente, Maria João Remião, Fernando |
| Author_xml | – sequence: 1 fullname: Silva, Bárbara – sequence: 2 fullname: Fernandes, Carla – sequence: 3 fullname: Tiritan, Maria Elizabeth – sequence: 4 fullname: Pinto, Madalena M.M. – sequence: 5 fullname: Valente, Maria João – scopusid: 7201413997 sequence: 6 givenname: Marcia orcidid: 0000-0001-9884-4751 surname: Carvalho fullname: Carvalho, Marcia – sequence: 7 fullname: Guedes de Pinho, Paula – sequence: 8 fullname: Remião, Fernando |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27594923$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc1u1TAQhS1URNsLD8AGhV2RGrBjJ3E2SOjyKxXBAthajjO5cZVrp7YTNbs-CLwAj9UnwVHaK9iw8khzvjMzPqfoyFgDCD0l-CXBuHzlCWGkSjEpUkwzls4P0AnhBU55VdKjQ13kx-jU-0uMc1IU2SN0nJV5xaqMnqDf20472SdgpAnaOvC2H2NhEtsmSoZOLzOTBpyeZNAT-GSIIjAh0Sa5vfnZwy7ind51_vbm13kiTXNv5qEHFRkd5gQm2Y9yNTaJmoMN9lqrpRUH0XOW7iF0cw8GGm2v52F2NiLglulnn99-_fHiMXrYyt7Dk7t3g76_f_dt-zG9-PLh0_bNRariSSFtM8WIrFtWUl7WPFOY0arJCwVSZSWvWUEoqSSWOalYo2JR57KhDCitZcZLukGvV99hrPfQqHhr_CExOL2XbhZWavFvx-hO7OwkWMU5ZUU0OLszcPZqBB_EXnsFfS8N2NELwvOqJLyMi2wQWaXKWe8dtIcxBIslY7FmLGLGYslYzJF59vd-B-I-1CjIVoGPLbMDJy7t6Ez8s_-6Pl8hp6QchINJ-yAXIuNsgSijfwCo8Mch |
| CitedBy_id | crossref_primary_10_1002_chir_22981 crossref_primary_10_1016_j_jchromb_2018_10_002 crossref_primary_10_1016_j_jchromb_2023_123824 crossref_primary_10_3390_molecules28052121 crossref_primary_10_1007_s11419_017_0359_8 crossref_primary_10_1021_acs_analchem_9b05339 crossref_primary_10_1002_elps_202200182 crossref_primary_10_1007_s10337_020_03860_9 crossref_primary_10_1039_D0NJ05065B crossref_primary_10_3390_chemosensors9110304 crossref_primary_10_3390_molecules27072057 crossref_primary_10_1016_j_toxlet_2018_07_030 crossref_primary_10_1016_j_chroma_2020_461359 crossref_primary_10_1016_j_trac_2024_117733 crossref_primary_10_1007_s00213_018_5067_5 crossref_primary_10_1016_j_forsciint_2019_110105 crossref_primary_10_1016_j_trac_2016_11_008 crossref_primary_10_1016_j_neubiorev_2018_07_015 crossref_primary_10_1016_j_chroma_2024_464628 crossref_primary_10_1016_j_forsciint_2020_110528 crossref_primary_10_1080_03602532_2018_1448867 crossref_primary_10_1002_elps_201900085 crossref_primary_10_1016_j_fsisyn_2020_01_019 crossref_primary_10_3390_ph15030368 crossref_primary_10_1093_jat_bkx074 crossref_primary_10_1016_j_chroma_2020_461256 crossref_primary_10_1016_j_chroma_2023_464152 crossref_primary_10_1002_chir_23268 crossref_primary_10_3390_molecules24050865 crossref_primary_10_1016_j_jchromb_2023_123836 crossref_primary_10_1080_15422119_2017_1326939 crossref_primary_10_1093_chromsci_bmz008 crossref_primary_10_1016_j_trac_2020_116090 crossref_primary_10_1016_j_taap_2020_114970 crossref_primary_10_3390_sym9100206 crossref_primary_10_3390_ijms24032680 crossref_primary_10_3390_molecules26185477 crossref_primary_10_1039_C6AY03176E crossref_primary_10_1016_j_chroma_2020_461846 crossref_primary_10_1016_j_jpba_2023_115897 crossref_primary_10_3390_molecules25081931 crossref_primary_10_1093_clinchem_hvad210 crossref_primary_10_3390_molecules24040791 crossref_primary_10_1002_elps_202400092 crossref_primary_10_1007_s11419_019_00468_z crossref_primary_10_1134_S106193482210015X |
| Cites_doi | 10.1111/bph.12951 10.1002/chir.530060214 10.1016/j.chroma.2009.10.022 10.1016/j.ejphar.2012.11.020 10.1002/chir.22341 10.1016/j.jchromb.2006.05.011 10.1007/s00204-014-1278-7 10.1016/j.chroma.2012.11.001 10.1016/j.genhosppsych.2012.06.005 10.1016/j.annemergmed.2012.01.005 10.1007/s00204-014-1209-7 10.1016/S0379-0738(98)00104-2 10.1016/j.jemermed.2012.09.147 10.1002/elps.201400077 10.1007/s00204-013-1163-9 10.1007/s11419-015-0298-1 10.1007/s10337-013-2469-8 10.1007/s00204-011-0749-3 10.1007/s10565-011-9208-4 10.1016/j.forsciint.2014.09.007 10.1016/S0379-0738(97)00108-4 10.1007/s00204-012-0815-5 10.1016/0091-3057(94)00348-3 10.1016/j.aca.2011.08.038 10.1021/ac00094a026 10.1002/elps.201100570 10.1124/jpet.115.229500 10.1007/s11419-015-0270-0 10.1002/chir.22423 10.1016/j.chroma.2012.07.058 10.1016/j.chroma.2012.04.011 10.1007/s11419-015-0299-0 10.1093/toxsci/kfu108 10.1016/S0379-0738(03)00096-3 10.1007/s11419-015-0268-7 10.1007/s00204-013-1078-5 10.1016/j.cbi.2006.12.003 10.1002/chir.22112 10.1002/jssc.201401052 10.1016/0379-0738(94)01669-0 10.1016/j.chroma.2005.12.071 10.1002/elps.201400085 10.1007/s00204-003-0510-7 10.1016/j.jpba.2015.12.023 10.1021/jo052554w 10.1002/chir.22048 10.1016/j.chroma.2012.09.079 10.1002/chir.22414 |
| ContentType | Journal Article |
| Copyright | Japanese Association of Forensic Toxicology and Springer Japan 2016 Japanese Association of Forensic Toxicology and Springer Japan 2016 |
| Copyright_xml | – notice: Japanese Association of Forensic Toxicology and Springer Japan 2016 – notice: Japanese Association of Forensic Toxicology and Springer Japan 2016 |
| DBID | RCLKO C6C NPM AAYXX CITATION 7X8 5PM |
| DOI | 10.1007/s11419-016-0324-y |
| DatabaseName | RCAAP open access repository Springer_OA刊 PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef PubMed |
| Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Medicine |
| DissertationSchool | Repositório Institucional da Universidade Fernando Pessoa |
| EISSN | 1860-8973 |
| EndPage | 385 |
| ExternalDocumentID | 10_1007_s11419_016_0324_y 27594923 10284_10034 |
| Genre | Journal Article |
| GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29H 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 5GY 5VS 67Z 6NX 8TC 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BGNMA CAG COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 E3Z EBLON EBS EIOEI EJD EN4 ESBYG FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG5 HG6 HLICF HMJXF HRMNR HVGLF HZ~ IHE IJ- IKXTQ ITM IWAJR IXC IXE IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV KPH LLZTM M4Y MA- N2Q NPVJJ NQJWS NU0 O9- O93 O9I O9J P9S PF0 PT4 QOR QOS R89 R9I RCLKO ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7W Z7X Z84 ZMTXR ZOVNA ~A9 AAFGU AAPBV AAYFA ABFGW ABKAS ACBMV ACBRV ACBYP ACIGE ACIPQ ACTTH ACVWB ACWMK ADMDM ADOXG AEFTE AESTI AEVTX AFNRJ AGGBP AIMYW AJDOV AKQUC C6C UNUBA NPM AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c492t-f2c41abf47387b82c0439d56ceac278b461319a0a5194dca0ab5ad34e33ba2873 |
| IEDL.DBID | U2A |
| ISSN | 1860-8965 |
| IngestDate | Tue Sep 17 21:17:37 EDT 2024 Fri Oct 25 04:00:41 EDT 2024 Thu Sep 12 16:36:47 EDT 2024 Wed Oct 16 00:02:26 EDT 2024 Sat Dec 16 12:00:51 EST 2023 Fri Nov 08 15:43:55 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Synthetic cathinones Legal highs MDPV enantiomer Enantioresolution Cytotoxicity according to enantiomers |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c492t-f2c41abf47387b82c0439d56ceac278b461319a0a5194dca0ab5ad34e33ba2873 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-9884-4751 |
| OpenAccessLink | http://link.springer.com/10.1007/s11419-016-0324-y |
| PMID | 27594923 |
| PQID | 1859718761 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4988346 proquest_miscellaneous_1859718761 crossref_primary_10_1007_s11419_016_0324_y pubmed_primary_27594923 springer_journals_10_1007_s11419_016_0324_y rcaap_revistas_10284_10034 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-07-01 |
| PublicationDateYYYYMMDD | 2016-07-01 |
| PublicationDate_xml | – month: 07 year: 2016 text: 2016-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Tokyo |
| PublicationPlace_xml | – name: Tokyo – name: Japan |
| PublicationTitle | Forensic toxicology |
| PublicationTitleAbbrev | Forensic Toxicol |
| PublicationTitleAlternate | Forensic Toxicol |
| PublicationYear | 2016 |
| Publisher | Springer Springer Japan |
| Publisher_xml | – name: Springer – name: Springer Japan |
| References | CarvalhoMMilhazesNRemiãoFBorgesFFernandesEAmadoFMonksTJCarvalhoFLourdes BastosMHepatotoxicity of 3,4-methylenedioxyamphetamine and α-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugatesArch Toxicol20047816241:CAS:528:DC%2BD2cXmtlGjug%3D%3D10.1007/s00204-003-0510-714586543 WeissJATaschwerMKunertOSchmidMGAnalysis of a new drug of abuse: cathinone derivative 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-oneJ Sep Sci2015388258281:CAS:528:DC%2BC2MXjslChsro%3D10.1002/jssc.20140105225545103 UchiyamaNShimokawaYKikura-HanajiriRDemizuYGodaYHakamatsukaTA synthetic cannabinoid FDU-NNEI, two 2-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N-OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal productsForensic Toxicol2015332442591:CAS:528:DC%2BC2MXivFWnsbg%3D10.1007/s11419-015-0268-7262578334525202 ScarcellaDTagliaroFTurrinaSManettoGNakaharaYSmithFPMarigoMOptimization of a simple method for the chiral separation of phenethylamines of forensic interest based on cyclodextrin complexation capillary electrophoresis and its preliminary application to the analysis of human urine and hairForensic Sci Int19978933461:CAS:528:DyaK2sXmtl2rtbY%3D10.1016/S0379-0738(97)00108-49306662 GreggRABaumannMHPartillaJSBonanoJSVougaATallaridaCSVelvadapuVSmithGRPeetMMReitzABNegusSSRawlsSMStereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in ratsBr J Pharmacol20151728838941:CAS:528:DC%2BC2MXks1Crtw%3D%3D10.1111/bph.1295125255824 LeBelleMJSavardCDawsonBABlackDBKatyalLKZrcekFByAWChiral identification and determination of ephedrine, pseudoephedrine, methamphetamine and methcathinone by gas chromatography and nuclear magnetic resonanceForensic Sci Int1995712152231:CAS:528:DyaK2MXlslCmtbs%3D10.1016/0379-0738(94)01669-07713461 JirovskyDLemrKSevcikJSmyslBStranskyZMethamphetamine—properties and analytical methods of enantiomer determinationForensic Sci Int19989661701:CAS:528:DyaK1cXntVCnur0%3D10.1016/S0379-0738(98)00104-29800366 WolrabDFruhaufPMoulisovaAKucharMGernerCLindnerWKohoutMChiral separation of new designer drugs (cathinones) on chiral ion-exchange type stationary phasesJ Pharm Biomed Anal201512030631510.1016/j.jpba.2015.12.02326765268 FernandesCTiritanMECassQKairysVFernandesMXPintoMEnantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phasesJ Chromatogr A2012124160681:CAS:528:DC%2BC38XmvFGgtLw%3D10.1016/j.chroma.2012.04.01122552201 GodoyPHewittNJAlbrechtUAndersenMEAnsariNBhattacharyaSRecent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArch Toxicol201387131515301:CAS:528:DC%2BC3sXhtlahtr3N10.1007/s00204-013-1078-5239749803753504 LiauASLiuJTLinLCChiuYCShuYRTsaiCCLinCHOptimization of a simple method for the chiral separation of methamphetamine and related compounds in clandestine tablets and urine samples by β-cyclodextrine modified capillary electrophoresis: a complementary method to GC-MSForensic Sci Int200313417241:CAS:528:DC%2BD3sXkvFyrtro%3D10.1016/S0379-0738(03)00096-312842352 EMCDDA-Europol (2014) Annual report on the implementation of council decision 2005/387/JHA.http://www.emcdda.europa.eu/attachements.cfm/att_212366_EN_EMCDDA-Europol%202012%20Annual%20Report_final.pdf. Accessed 3 Dec 2014 RasmussenLBOlsenKHJohansenSSChiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MSJ Chromatogr B20068421361411:CAS:528:DC%2BD28XpvFegsbw%3D10.1016/j.jchromb.2006.05.011 den HollanderBSundstromMPelanderAOjanperaIMervaalaEKorpiERKankuriEKeto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedroneToxicol Sci201414112013110.1093/toxsci/kfu108 BorekHAHolstegeCPHyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovaleroneAnn Emerg Med20126010310510.1016/j.annemergmed.2012.01.00522387085 LammerhoferMChiral recognition by enantioselective liquid chromatography: mechanisms and modern chiral stationary phasesJ Chromatogr A2010121781485610.1016/j.chroma.2009.10.02219906381 NameraAKawamuraMNakamotoASaitoTNagaoMComprehensive review of the detection methods for synthetic cannabinoids and cathinonesForensic Toxicol2015331751941:CAS:528:DC%2BC2MXktFejurY%3D10.1007/s11419-015-0270-0262578314525208 JohnsonLAJohnsonRLPortierRBCurrent “legal highs”J Emerg Med2013441108111510.1016/j.jemermed.2012.09.14723528960 AturkiZSchmidMGChankvetadzeBFanaliSEnantiomeric separation of new cathinone derivatives designer drugs by capillary electrochromatography using a chiral stationary phase, based on amylose tris(5-chloro-2-methylphenylcarbamate)Electrophoresis201435324232491:CAS:528:DC%2BC2cXhtFCgu7fK10.1002/elps.20140008524854346 CarvalhoMCalmoHCostaVMCapelaJPPontesHRemiãoFCarvalhoFde LourdesBastos MToxicity of amphetamines: an updateArch Toxicol201286116712311:CAS:528:DC%2BC38Xjt1elsr0%3D10.1007/s00204-012-0815-522392347 SuzukiMDeschampsJRJacobsonAERiceKCChiral resolution and absolute configuration of the enantiomers of the psychoactive “designer drug” 3,4-methylenedioxypyrovaleroneChirality2015272872931:CAS:528:DC%2BC2MXksF2htLw%3D10.1002/chir.2242325727807 MohrSTaschwerMSchmidMGChiral separation of cathinone derivatives used as recreational drugs by HPLC-UV using a CHIRALPAK(R) AS-H column as stationary phaseChirality2012244864921:CAS:528:DC%2BC38Xmt1antrY%3D10.1002/chir.2204822544697 BijlsmaLMiserezBIbáñezMVicentCGuillamónERamseyJHernándezFIdentification and characterization of a novel cathinone derivative 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidin-1-yl)-ethanone seized by customs in JerseyForensic Toxicol2016341441501:CAS:528:DC%2BC2MXhvVOmsr7O10.1007/s11419-015-0299-0 GannonBMWilliamsonASuzukiMRiceKCFantegrossiWEStereoselective effects of abused “bath salt” constituent 3,4-methylenedioxypyrovalerone in mice: drug discrimination, locomotor activity, and thermoregulationJ Pharmacol Exp Ther201635661562310.1124/jpet.115.229500267699174767395 GlennonRAYoungRMartinBRDal CasonTAMethcathione (“cat”): an enantiomeric potency comparisonPharmacol Biochem Behav1995506016061:CAS:528:DyaK2MXksVGiurs%3D10.1016/0091-3057(94)00348-37617707 WeissJAMohrSSchmidMGIndirect chiral separation of new recreational drugs by gas chromatography-mass spectrometry using trifluoroacetyl-l-prolyl chloride as chiral derivatization reagentChirality2015272112151:CAS:528:DC%2BC2cXhvFKmtb%2FI10.1002/chir.2241425418781 KatselouMPapoutsisINikolaouPSpiliopoulouCAthanaselisSα-PVP (“flakka”): a new synthetic cathinone invades the drug arenaForensic Toxicol20163441501:CAS:528:DC%2BC2MXhvVOmsr7N10.1007/s11419-015-0298-1 ValenteMJHenriqueRVilas-BoasVSilvaRde LourdesBastos MCarvalhoFde PinhoPGCarvalhoMCocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cellsArch Toxicol2012862492611:CAS:528:DC%2BC3MXht1ygs7fO10.1007/s00204-011-0749-321983858 TaschwerMSeidlYMohrSSchmidMGChiral separation of cathinone and amphetamine derivatives by HPLC/UV using sulfated ss-cyclodextrin as chiral mobile phase additiveChirality2014264114181:CAS:528:DC%2BC2cXptlOhtro%3D10.1002/chir.2234124909415 FernandesCPalmeiraASantosATiritanMEAfonsoCPintoMMEnantioresolution of chiral derivatives of xanthones on (S, S)-Whelk-O1 and l-phenylglycine stationary phases and chiral recognition mechanism by docking approach for (S, S)-Whelk-O1Chirality201325891001:CAS:528:DC%2BC38XhvVSltrfI10.1002/chir.2211223229954 BaumannMHPartillaJSLehnerKRPsychoactive “bath salts”: not so soothingEur J Pharmacol2013698151:CAS:528:DC%2BC38XhvVWisb7P10.1016/j.ejphar.2012.11.02023178799 FernandesCTiritanMEPintoMSmall molecules as chromatographic tools for HPLC enantiomeric resolution: pirkle-type chiral stationary phases evolutionChromatographia2013768718971:CAS:528:DC%2BC3sXhtFOrs7fM10.1007/s10337-013-2469-8 MerolaGFuHTagliaroFMacchiaTMcCordBRChiral separation of 12 cathinone analogs by cyclodextrin-assisted capillary electrophoresis with UV and mass spectrometry detectionElectrophoresis201435323132411:CAS:528:DC%2BC2cXhtVWgt7jM10.1002/elps.20140007724947960 BarbosaDJSerratRMirraSQuevedoMde BarredaEGAvillaJFernandesEde LourdesBastos MCapelaJPCarvalhoFSorianoEMDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent mannerArch Toxicol201488156115721:CAS:528:DC%2BC2cXitlers7s%3D10.1007/s00204-014-1209-724522274 AraújoAMValenteMJCarvalhoMda SilvaDDGasparHCarvalhoFde LourdesBastos Mde PinhoPGRaising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinonesArch Toxicol20158975777110.1007/s00204-014-1278-724903018 MohrSPilajSSchmidMGChiral separation of cathinone derivatives used as recreational drugs by cyclodextrin-modified capillary electrophoresisElectrophoresis201233162416301:CAS:528:DC%2BC38XptFCqsrc%3D10.1002/elps.20110057022736365 GawleyREDo the terms “% ee” and “% de” make sense as expressions of stereoisomer composition or stereoselectivity?J Org Chem200671241124161:CAS:528:DC%2BD28XhsFartbo%3D10.1021/jo052554w165267912536600 EMCDDA (2015) New psychoactive substances in Europe. European Monitoring Centre for Drugs and Drug Addiction. http://www.emcdda.europa.eu/attachments.cfm/att_235958_EN_TD0415135ENN.pdf#serch=‘EMCDDA%2C+2015%2C+New+psychoactive+substances+in+Europe’. Accessed 10 May 2015 LurieISKleinRFDal CasonTALeBelleMJBrenneisenRWeinbergerREChiral resolution of cationic drugs of forensic interest by capillary electrophoresis with mixtures of neutral and anionic cyclodextrinsAnal Chem199466401940261:CAS:528:DyaK2cXmsVyiurg%3D10.1021/ac00094a0267810901 GuillouzoACorluAAninatCGlaiseDMorelFGuguen-GuillouzoCThe human hepatoma HepaRG cells: a highly differ 7617707 - Pharmacol Biochem Behav. 1995 Apr;50(4):601-6 9800366 - Forensic Sci Int. 1998 Aug 31;96(1):61-70 16445926 - J Chromatogr A. 2006 Jul 7;1120(1-2):75-81 24522274 - Arch Toxicol. 2014 Aug;88(8):1561-72 26257833 - Forensic Toxicol. 2015;33(2):244-259 23178799 - Eur J Pharmacol. 2013 Jan 5;698(1-3):1-5 26257831 - Forensic Toxicol. 2015;33(2):175-194 22889602 - J Chromatogr A. 2012 Dec 21;1269:143-53 23528960 - J Emerg Med. 2013 Jun;44(6):1108-15 25280452 - Forensic Sci Int. 2014 Nov;244:e56-9 22392347 - Arch Toxicol. 2012 Aug;86(8):1167-231 26765268 - J Pharm Biomed Anal. 2016 Feb 20;120:306-15 22898445 - Gen Hosp Psychiatry. 2012 Nov-Dec;34(6):647-50 24903018 - Arch Toxicol. 2015 May;89(5):757-71 22258563 - Cell Biol Toxicol. 2012 Apr;28(2):69-87 23229954 - Chirality. 2013 Feb;25(2):89-100 16526791 - J Org Chem. 2006 Mar 17;71(6):2411-6 12842352 - Forensic Sci Int. 2003 Jun 24;134(1):17-24 24913801 - Toxicol Sci. 2014 Sep;141(1):120-31 25545103 - J Sep Sci. 2015 Mar;38(5):825-8 7810901 - Anal Chem. 1994 Nov 15;66(22):4019-26 22023854 - Anal Chim Acta. 2011 Nov 14;706(2):205-22 19906381 - J Chromatogr A. 2010 Feb 5;1217(6):814-56 25418781 - Chirality. 2015 Mar;27(3):211-5 22544697 - Chirality. 2012 Jun;24(6):486-92 17241619 - Chem Biol Interact. 2007 May 20;168(1):66-73 24909415 - Chirality. 2014 Aug;26(8):411-8 9306662 - Forensic Sci Int. 1997 Sep 19;89(1-2):33-46 21983858 - Arch Toxicol. 2012 Feb;86(2):249-61 26769917 - J Pharmacol Exp Ther. 2016 Mar;356(3):615-23 24317389 - Arch Toxicol. 2014 Jan;88(1):15-45 23974980 - Arch Toxicol. 2013 Aug;87(8):1315-530 24854346 - Electrophoresis. 2014 Nov;35(21-22):3242-9 22736365 - Electrophoresis. 2012 Jun;33(11):1624-30 23058937 - J Chromatogr A. 2012 Dec 21;1269:352-9 14586543 - Arch Toxicol. 2004 Jan;78(1):16-24 16797258 - J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Oct 2;842(2):136-41 24947960 - Electrophoresis. 2014 Nov;35(21-22):3231-41 22387085 - Ann Emerg Med. 2012 Jul;60(1):103-5 22552201 - J Chromatogr A. 2012 Jun 8;1241:60-8 25727807 - Chirality. 2015 Apr;27(4):287-93 23174478 - J Chromatogr A. 2012 Dec 21;1269:189-97 25255824 - Br J Pharmacol. 2015 Feb;172(3):883-94 7713461 - Forensic Sci Int. 1995 Feb 28;71(3):215-23 C Fernandes (324_CR10) 2013; 76 RA Glennon (324_CR11) 1995; 50 MJ Valente (324_CR40) 2012; 86 MH Baumann (324_CR6) 2013; 698 M Katselou (324_CR9) 2016; 34 C Fernandes (324_CR44) 2012; 1269 SA Martin (324_CR36) 1994; 6 HH Gerets (324_CR48) 2012; 28 M Taschwer (324_CR23) 2014; 244 S Mohr (324_CR17) 2012; 33 324_CR1 IS Lurie (324_CR16) 1994; 66 324_CR4 D Jirovsky (324_CR12) 1998; 96 DJ Barbosa (324_CR41) 2014; 88 L Bijlsma (324_CR7) 2016; 34 ME Sousa (324_CR37) 2006; 1120 C Fernandes (324_CR42) 2013; 25 RE Gawley (324_CR38) 2006; 71 324_CR35 S Mohr (324_CR22) 2012; 1269 A Namera (324_CR5) 2015; 33 C Fernandes (324_CR43) 2012; 1241 AS Liau (324_CR18) 2003; 134 LA Johnson (324_CR2) 2013; 44 JA Weiss (324_CR24) 2015; 27 S Mohr (324_CR26) 2012; 24 D Scarcella (324_CR19) 1997; 89 M Suzuki (324_CR28) 2015; 27 A Guillouzo (324_CR49) 2007; 168 M Carvalho (324_CR39) 2004; 78 HA Borek (324_CR34) 2012; 60 MJ Valente (324_CR3) 2014; 88 G Merola (324_CR20) 2014; 35 RA Gregg (324_CR14) 2015; 172 N Uchiyama (324_CR8) 2015; 33 AM Araújo (324_CR32) 2015; 89 LB Rasmussen (324_CR13) 2006; 842 P Godoy (324_CR47) 2013; 87 Z Aturki (324_CR31) 2014; 35 MJ LeBelle (324_CR21) 1995; 71 RW Perera (324_CR27) 2012; 1269 M Carvalho (324_CR50) 2012; 86 TM Penders (324_CR33) 2012; 34 B den Hollander (324_CR51) 2014; 141 M Lammerhofer (324_CR46) 2010; 1217 D Wolrab (324_CR30) 2015; 120 A Cavazzini (324_CR45) 2011; 706 JA Weiss (324_CR25) 2015; 38 BM Gannon (324_CR15) 2016; 356 M Taschwer (324_CR29) 2014; 26 |
| References_xml | – volume: 172 start-page: 883 year: 2015 ident: 324_CR14 publication-title: Br J Pharmacol doi: 10.1111/bph.12951 contributor: fullname: RA Gregg – volume: 6 start-page: 135 year: 1994 ident: 324_CR36 publication-title: Chirality doi: 10.1002/chir.530060214 contributor: fullname: SA Martin – volume: 1217 start-page: 814 year: 2010 ident: 324_CR46 publication-title: J Chromatogr A doi: 10.1016/j.chroma.2009.10.022 contributor: fullname: M Lammerhofer – volume: 698 start-page: 1 year: 2013 ident: 324_CR6 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2012.11.020 contributor: fullname: MH Baumann – volume: 26 start-page: 411 year: 2014 ident: 324_CR29 publication-title: Chirality doi: 10.1002/chir.22341 contributor: fullname: M Taschwer – volume: 842 start-page: 136 year: 2006 ident: 324_CR13 publication-title: J Chromatogr B doi: 10.1016/j.jchromb.2006.05.011 contributor: fullname: LB Rasmussen – volume: 89 start-page: 757 year: 2015 ident: 324_CR32 publication-title: Arch Toxicol doi: 10.1007/s00204-014-1278-7 contributor: fullname: AM Araújo – volume: 1269 start-page: 189 year: 2012 ident: 324_CR27 publication-title: J Chromatogr A doi: 10.1016/j.chroma.2012.11.001 contributor: fullname: RW Perera – volume: 34 start-page: 647 year: 2012 ident: 324_CR33 publication-title: Gen Hosp Psychiat doi: 10.1016/j.genhosppsych.2012.06.005 contributor: fullname: TM Penders – volume: 60 start-page: 103 year: 2012 ident: 324_CR34 publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2012.01.005 contributor: fullname: HA Borek – volume: 88 start-page: 1561 year: 2014 ident: 324_CR41 publication-title: Arch Toxicol doi: 10.1007/s00204-014-1209-7 contributor: fullname: DJ Barbosa – volume: 96 start-page: 61 year: 1998 ident: 324_CR12 publication-title: Forensic Sci Int doi: 10.1016/S0379-0738(98)00104-2 contributor: fullname: D Jirovsky – volume: 44 start-page: 1108 year: 2013 ident: 324_CR2 publication-title: J Emerg Med doi: 10.1016/j.jemermed.2012.09.147 contributor: fullname: LA Johnson – volume: 35 start-page: 3231 year: 2014 ident: 324_CR20 publication-title: Electrophoresis doi: 10.1002/elps.201400077 contributor: fullname: G Merola – volume: 88 start-page: 15 year: 2014 ident: 324_CR3 publication-title: Arch Toxicol doi: 10.1007/s00204-013-1163-9 contributor: fullname: MJ Valente – volume: 34 start-page: 41 year: 2016 ident: 324_CR9 publication-title: Forensic Toxicol doi: 10.1007/s11419-015-0298-1 contributor: fullname: M Katselou – volume: 76 start-page: 871 year: 2013 ident: 324_CR10 publication-title: Chromatographia doi: 10.1007/s10337-013-2469-8 contributor: fullname: C Fernandes – volume: 86 start-page: 249 year: 2012 ident: 324_CR40 publication-title: Arch Toxicol doi: 10.1007/s00204-011-0749-3 contributor: fullname: MJ Valente – volume: 28 start-page: 69 year: 2012 ident: 324_CR48 publication-title: Cell Biol Toxicol doi: 10.1007/s10565-011-9208-4 contributor: fullname: HH Gerets – volume: 244 start-page: e56 year: 2014 ident: 324_CR23 publication-title: Forensic Sci Int doi: 10.1016/j.forsciint.2014.09.007 contributor: fullname: M Taschwer – volume: 89 start-page: 33 year: 1997 ident: 324_CR19 publication-title: Forensic Sci Int doi: 10.1016/S0379-0738(97)00108-4 contributor: fullname: D Scarcella – volume: 86 start-page: 1167 year: 2012 ident: 324_CR50 publication-title: Arch Toxicol doi: 10.1007/s00204-012-0815-5 contributor: fullname: M Carvalho – volume: 50 start-page: 601 year: 1995 ident: 324_CR11 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(94)00348-3 contributor: fullname: RA Glennon – volume: 706 start-page: 205 year: 2011 ident: 324_CR45 publication-title: Anal Chim Acta doi: 10.1016/j.aca.2011.08.038 contributor: fullname: A Cavazzini – volume: 66 start-page: 4019 year: 1994 ident: 324_CR16 publication-title: Anal Chem doi: 10.1021/ac00094a026 contributor: fullname: IS Lurie – volume: 33 start-page: 1624 year: 2012 ident: 324_CR17 publication-title: Electrophoresis doi: 10.1002/elps.201100570 contributor: fullname: S Mohr – volume: 356 start-page: 615 year: 2016 ident: 324_CR15 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.115.229500 contributor: fullname: BM Gannon – volume: 33 start-page: 175 year: 2015 ident: 324_CR5 publication-title: Forensic Toxicol doi: 10.1007/s11419-015-0270-0 contributor: fullname: A Namera – volume: 27 start-page: 287 year: 2015 ident: 324_CR28 publication-title: Chirality doi: 10.1002/chir.22423 contributor: fullname: M Suzuki – volume: 1269 start-page: 143 year: 2012 ident: 324_CR44 publication-title: J Chromatogr A doi: 10.1016/j.chroma.2012.07.058 contributor: fullname: C Fernandes – volume: 1241 start-page: 60 year: 2012 ident: 324_CR43 publication-title: J Chromatogr A doi: 10.1016/j.chroma.2012.04.011 contributor: fullname: C Fernandes – volume: 34 start-page: 144 year: 2016 ident: 324_CR7 publication-title: Forensic Toxicol doi: 10.1007/s11419-015-0299-0 contributor: fullname: L Bijlsma – volume: 141 start-page: 120 year: 2014 ident: 324_CR51 publication-title: Toxicol Sci doi: 10.1093/toxsci/kfu108 contributor: fullname: B den Hollander – volume: 134 start-page: 17 year: 2003 ident: 324_CR18 publication-title: Forensic Sci Int doi: 10.1016/S0379-0738(03)00096-3 contributor: fullname: AS Liau – ident: 324_CR35 – volume: 33 start-page: 244 year: 2015 ident: 324_CR8 publication-title: Forensic Toxicol doi: 10.1007/s11419-015-0268-7 contributor: fullname: N Uchiyama – volume: 87 start-page: 1315 year: 2013 ident: 324_CR47 publication-title: Arch Toxicol doi: 10.1007/s00204-013-1078-5 contributor: fullname: P Godoy – volume: 168 start-page: 66 year: 2007 ident: 324_CR49 publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2006.12.003 contributor: fullname: A Guillouzo – ident: 324_CR1 – volume: 25 start-page: 89 year: 2013 ident: 324_CR42 publication-title: Chirality doi: 10.1002/chir.22112 contributor: fullname: C Fernandes – volume: 38 start-page: 825 year: 2015 ident: 324_CR25 publication-title: J Sep Sci doi: 10.1002/jssc.201401052 contributor: fullname: JA Weiss – volume: 71 start-page: 215 year: 1995 ident: 324_CR21 publication-title: Forensic Sci Int doi: 10.1016/0379-0738(94)01669-0 contributor: fullname: MJ LeBelle – volume: 1120 start-page: 75 year: 2006 ident: 324_CR37 publication-title: J Chromatogr A doi: 10.1016/j.chroma.2005.12.071 contributor: fullname: ME Sousa – volume: 35 start-page: 3242 year: 2014 ident: 324_CR31 publication-title: Electrophoresis doi: 10.1002/elps.201400085 contributor: fullname: Z Aturki – volume: 78 start-page: 16 year: 2004 ident: 324_CR39 publication-title: Arch Toxicol doi: 10.1007/s00204-003-0510-7 contributor: fullname: M Carvalho – volume: 120 start-page: 306 year: 2015 ident: 324_CR30 publication-title: J Pharm Biomed Anal doi: 10.1016/j.jpba.2015.12.023 contributor: fullname: D Wolrab – volume: 71 start-page: 2411 year: 2006 ident: 324_CR38 publication-title: J Org Chem doi: 10.1021/jo052554w contributor: fullname: RE Gawley – ident: 324_CR4 – volume: 24 start-page: 486 year: 2012 ident: 324_CR26 publication-title: Chirality doi: 10.1002/chir.22048 contributor: fullname: S Mohr – volume: 1269 start-page: 352 year: 2012 ident: 324_CR22 publication-title: J Chromatogr A doi: 10.1016/j.chroma.2012.09.079 contributor: fullname: S Mohr – volume: 27 start-page: 211 year: 2015 ident: 324_CR24 publication-title: Chirality doi: 10.1002/chir.22414 contributor: fullname: JA Weiss |
| SSID | ssj0051662 |
| Score | 2.332692 |
| Snippet | Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral... Abstract Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist... Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral... |
| SourceID | pubmedcentral proquest crossref pubmed springer rcaap |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 372 |
| SubjectTerms | Cytotoxicity according to enantiomers Enantioresolution Forensic Medicine Forensic Science Legal highs MDPV enantiomer Medical Law Medicinal Chemistry Medicine Medicine & Public Health Original Original Article Pharmacology/Toxicology Synthetic cathinones |
| Title | Chiral enantioresolution of cathinone derivatives present in “legal highs”, and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV) |
| URI | http://hdl.handle.net/10284/10034 https://link.springer.com/article/10.1007/s11419-016-0324-y https://www.ncbi.nlm.nih.gov/pubmed/27594923 https://search.proquest.com/docview/1859718761 https://pubmed.ncbi.nlm.nih.gov/PMC4988346 |
| Volume | 34 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB61XQkhVQjKoymwMhIHHjWKE-d1XC0tFWgRBxaVU2QnjhqBktUmRc2tPwT-AD-rv4SZPHa1Wjgg5ZAoju1oxp7PHs83AM_tVJMwU45gNeVSRYIr5QueKjfUvi0zoWhrYPbRP5vL9-fe-Q44q62L4tubwSPZTtTrWDchKd5G4AIYQQBvdmHkERsa6vDcmQyzryf8NomoCH2bh5HvDZ7Mv1WxaYu2AOb2OcnRMlFqseU0bW3R6V2404NINumkfg92THEAt2a9m_wA9rvNONbFGN2H39OLHGtmhk695CWusHuFY2XGiLg1L8rCsBS18UdLBF6xRReWxPKC3Vz__G7QkDCiNq5urn8dM1WkQ2VVm0inTUHB1tThDK-kqcu6vMI-4StsyD2WnBJWN2josKvlVbNoliV-YpbU-ovZ209fXj6A-enJ5-kZ75M08ERGTs0zJ5FC6UwGbhjo0Eko1jb1_ARndCcItUS8ICJlK4SKMk3wRnsqdaVxXa1wueY-hD36x0NgymTK0cYgYnVxIUbgUAlbJx4-ZVr4FrwaxBUvOi6OeM26TLKN6bwayTZuLHg2CDTGEUNuEFWY8rKKEaFEaJEDX1jwqBPwqjon8CKirLMg2BD9qgCxcW--KfKLlpVbRmHoSuzkUaskMZ3SRoCP7SGEk9RLV1rwetCcuJ8rqn__wtF_lX4Mtx1SbeFwET2BvXp5aZ4iYKr1GEaTd18_nIxhd-pPx-14-QNhVBZ1 |
| link.rule.ids | 230,315,783,787,888,27936,27937,41093,41132,41535,42162,42201,42604,51588,52123,52246 |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BrgSVEI_ySnkZiQOPuooTx0mOVWlZaLfisEXtKbITR42KktUmiwin_hD4A_ys_hLGeXS1LBwq7SGrJPY4nng-Z2a-AXhlJ8pMZkIRrCaUy5BRKQWjiXQDJWyeMmk-DYwPxeiIfzr2jrs87rKPdu9dks1KvUh2Y9wk3DDcASMKoPV1GHKHCWcAw-0PJ_u7_QLsMdHUEWWBsGkQCq93Zv6rkWVztIIxV0Mlh7NYyumK37QxR3t3YNIPpI1COduaV2or_vEXx-MVR3oXbnfwlGy3-nQPrul8HW6MOwf8OtxqP_ORNnvpPvzeOc1QYKJNPE1W4N69U2VSpMRQwmZ5kWuSoJ5_ayjGSzJtE55IlpOL859fNZooYkiTy4vzX5tE5knfWNmU6GmKW5AFKTnBX1xXRVV8R5nwFHbkbnJqSmHXaEJRVHwk03pW4C16Znp_PX7_-cubB3C0tzvZGdGu_AONeehUNHVizqRKue8Gvgqc2GTxJp6I0VY4fqA4IhEWSlsiCOVJjAfKk4nLtesqiRtB9yEMzBgfA5E6lY7SGrGwi1s8Azsls1Xs4b9UMWHB214LomnL8hEt-JzNbEQmEs7MRlRb8LLXkwjfReNgkbku5mWE2CdEW-8LZsGjVm8um3N8LzRkeBb4Sxp1eYHh-V4-k2enDd83D4PA5SjkRqN7kYn_xq0D9ofgkBspXW7Bu16Xom4VKv8_hI0rXf0Cbo4m44Po4OPh_hNYcxrFNAHLT2FQzeb6GcKySj3vXsM_m2M0Wg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZtAqFQQpu-nL5U6KGPiKwsWbaPZdMlfWzIoSm5GcmSiaHYZu2E-JYf0v6B_qz8ks74kWXZ9lDwwca2JDNjzSfNzDeEvJ5Yg8K0DMCqZVLHnGmtOLNaREZNZMY1bg3Mj9Thifx8GpwOdU7rMdp9dEn2OQ3I0lQ0-5XN9peJb1xi8g2H1TAgAtbeJpsSa6ajt1ZNx6k44KqrKMojNWFRrILRrfm3JlYN0xraXA-a3FykWldrHtTOMM3uke0BUdIPvQrcJ7dcsUO25oPPfIfc7XfmaJ9w9ID8np7l0DJ1GAKTl7DcHrSPlhlFFte8KAtHLajmRccKXtOqz1GieUGvr37-cGBVKPIc19dXv_aoLuzYWN1V1enqUdAljziFI22bsikvYUxwCzoSe5Jh9eoWrB4Mtbxsq3ZRwitugb2_mR8cf3_7kJzMPn6bHrKhYgNLZew3LPNTybXJZCii0ER-iom3NlApTO9-GBkJ4IHHeqIBN0qbwokJtBXSCWE0rN3EI7KB3_iEUO0y7RvnAL4KWJUhUtR8YtIArjLDlUfejeJKqp6YI1lSMKNsEwxeQ9kmrUdejQJN4PdBn4guXHleJwBXYjDPoeIeedwL-KY5Pwxi5K_zSLgi-psHkJp79U6Rn3UU3TKOIiFhkLudkiQYsg1oH_oDPCdxlEJ65P2oOckwcdT__oTd_3r6Jdk6PpglXz8dfXlK7vidloeMx8_IRrM4d88BSDXmRfez_AEXBhuJ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chiral+enantioresolution+of+cathinone+derivatives+present+in+%E2%80%9Clegal+highs%E2%80%9D%2C+and+enantioselectivity+evaluation+on+cytotoxicity+of+3%2C4-methylenedioxypyrovalerone+%28MDPV%29&rft.jtitle=Forensic+toxicology&rft.au=Silva%2C+B%C3%A1rbara&rft.au=Fernandes%2C+Carla&rft.au=Tiritan%2C+Maria+Elizabeth&rft.au=Pinto%2C+Madalena+M.M.&rft.date=2016-07-01&rft.issn=1860-8965&rft.eissn=1860-8973&rft.volume=34&rft.issue=2&rft.spage=372&rft.epage=385&rft_id=info:doi/10.1007%2Fs11419-016-0324-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11419_016_0324_y |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1860-8965&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1860-8965&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1860-8965&client=summon |